SEARCH

SEARCH BY CITATION

References

  • Ali, H. & Pearce, F.L. (1985). Isolation and properties of cardiac and other mast cells from the rat and guinea-pig. Agents Actions, 16, 138140.
  • Banner, K.H., Roberts, N.M. & Page, C.P. (1995). Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis. Br. J. Pharmacol., 116, 31693174.
  • Barnes, P.J. (1995). Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J., 8, 457462.
  • Barnette, M.S., Manning, C.D., Cieslinski, L.B., Burman, M., Christensen, S.B. & Torphy, T.J. (1995). The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity. J. Pharmacol. Exp. Ther., 273, 674679.
  • Beavo, J.A., Conti, M. & Heaslip, R.J. (1994). Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol., 46, 399405.
  • Beavo, J.A. & Reifsnyder, D.H. (1990). Primary sequence of cyclic nucleotide PDE isozymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 151155.
  • Chan, S.C. & Hanifin, J.M. (1993). Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes. J. Lab. Clin. Med., 121, 4451.
  • Dent, G., Giembycz, M.A., Rabe, K.F. & Barnes, P.J. (1991). Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by ‘type IV-selective PDE inhibitors. Br. J. Pharmacol., 103, 13391346.
  • Ennis, M. (1991). Current techniques of histamine determination: automated fluorometric assays. Handbook Exp. Pharmacol., 97, 3138.
  • Essayan, D.M., Huang S-K., Undem, B.J., Kagey-Sobotka, A. & Lichtenstein, L.M. (1994). Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J. Immunol., 153, 34083416.
  • Frossard, N., Landry, Y., Pauli, G. & Ruckstuhl, M. (1981). Effects of cyclic AMP- and cyclic GMP-phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br. J. Pharmacol., 73, 933938.
  • Fruman, D.A., Klee, C.B., Bierer, B.E. & Burakoff, S.J. (1992). Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl. Acad. Sci. U.S.A., 89, 36863690.
  • Gilbert, H.S. & Ornstein, L. (1975). Basophil counting with a new staining method using alcian blue. Blood, 46, 279282.
  • Hatzelman, A., Tenor, H. & Schudt, C. (1995). Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Br. J. Pharmacol., 114, 821831.
  • Hichami, A., Boichot, E., Germain, N., Legrand, A., Moodley, I. & Lagente, V. (1995). Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells. Eur. J. Pharmacol., 291, 9197.
  • Lichtenstein, L.M. & Margolis, S. (1968). Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science, 161, 902903.
  • Nicholson, C.D., Challiss, R.A.J. & Shahid, M. (1991). Differential modulation of tissue and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Phamacol. Sci., 12, 1927.
  • Nicholson, C.D. & Shahid, M. (1994). Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes – their potential utility in the therapy of asthma. Pulmon. Pharmacol., 7, 118.
  • Nielson, C.P., Vestal, R.E., Sturm, R.J. & Heaslip, R. (1990). Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol., 86, 801808.
  • Peachell, P.T., MacGlashan, D.W., Lichtenstein, L.M. & Schleimer, R.P. (1988). Regulation of human basophil and lung mast cell function by cAMP. J. Immunol., 140, 571579.
  • Peachell, P.T., Undem, B.J., Schleimer, R.P. MacGlashan, D.W., Lichtenstein, L.M., Cieslinski, L.B. & Torphy, T.J. (1992). Preliminary identification and role of phosphodiesterase isozymes in human basophils. J. Immunol., 148, 25032510.
  • Pearce, F.L. (1983). Mast cell heterogeneity. Trends Pharmacol. Sci., 4, 165167.
  • Reeves, M.L., Leigh, B.K. & England, P.J. (1987). The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem. J., 241, 535541.
  • Siraganian, R.P. (1974). An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem., 57, 383394.
  • Souness J.E., Carter, C.M., Diocee, B.K., Hassall, G.A., Wood, L.J. & Turner, N.C. (1991). Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. Biochem. Pharmacol., 42, 937945.
  • Souness, J.E., Griffin, M., Maslen, C., Ebsworth, K., Scott, L.C., Pollock, K., Palfreyman, M.N. & Karlsson, J-A. (1996). Evidence that cAMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low-affinity’ phosphodiesterase conformer. Br. J. Pharmacol., 118, 649658.
  • Souness, J.E., Maslen, C., Webber, S., Foster, M., Raeburn, D., Palfreyman, M.N., Ashton, M.J. & Karlsson, J-A. (1995). Suppresion of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Br. J. Pharmacol., 115, 3946.
  • Torphy, T.J. & Undem, B.J. (1991). Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax, 46, 512523.
  • Torphy, T.J., Zhou, H-L. & Cieslinski, L.B. (1992). Stimulation of beta adrenoceptors in a human monocyte cell line (U937) upregulated cyclic AMP-specific phosphodiesterase activity. J. Pharmacol. Exp. Ther., 263, 11951205.
  • Turner, N.C., Wood, L.J., Burns, F.M., Gueremy, T. & Souness, J.E. (1993). The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea pig peritoneal macrophages. Br. J. Pharmacol., 108, 876883.
  • Undem, B.J., Peachell, P.T. & Lichtenstein, L.M. (1988). Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. J. Pharmacol. Exp. Ther., 247, 209217.
  • Underwood, D.C., Osborn, R.R., Novak, L.B., Matthews, J.K., Newsholme, S.J., Undem, B.J., Hand, J.M. & Torphy, T.J. (1993). Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cAMP-specific phosphodiesterae inhibitor, rolipram. J. Pharmacol. Exp. Ther., 266, 306313.